| scholarly article | Q13442814 |
| P356 | DOI | 10.1039/C2MD20134H |
| P2093 | author name string | Takao Yamori | |
| Shinichi Sato | |||
| Hiroyuki Nakamura | |||
| Shinae Kizaka-Kondoh | |||
| Ayano Takeuchi | |||
| Hyun Seung Ban | |||
| Takahiro Kuchimaru | |||
| Makihito Hori | |||
| P2860 | cites work | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 |
| NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential | Q24656131 | ||
| Targeting HIF-1 for cancer therapy | Q27860504 | ||
| Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation | Q27860876 | ||
| Signal transduction to hypoxia-inducible factor 1 | Q28221115 | ||
| Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1 | Q28282227 | ||
| Hypoxia--a key regulatory factor in tumour growth | Q29547318 | ||
| Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein | Q29615931 | ||
| Development of HIF-1 inhibitors for cancer therapy | Q33703381 | ||
| In vivo imaging of HIF-active tumors by an oxygen-dependent degradation protein probe with an interchangeable labeling system | Q33784382 | ||
| HIF-1 as a target for drug development | Q35550217 | ||
| Versatile pharmacological actions of YC-1: anti-platelet to anticancer | Q35764741 | ||
| Hypoxia-inducible factors: central regulators of the tumor phenotype | Q36701590 | ||
| Targeting hypoxia cell signaling for cancer therapy | Q36784388 | ||
| Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004 - 2010). | Q37826426 | ||
| 1-[4-(N-Benzylamino)phenyl]-3-phenylurea derivatives as a new class of hypoxia-inducible factor-1alpha inhibitors | Q39852702 | ||
| Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer | Q39856479 | ||
| A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}. | Q39906110 | ||
| Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance | Q39946802 | ||
| Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226. | Q40078441 | ||
| Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2). | Q40241945 | ||
| Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines | Q41679901 | ||
| NO-independent stimulators of soluble guanylate cyclase | Q43558550 | ||
| Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells. | Q43564835 | ||
| Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole analogues as novel antiplatelet agents | Q43770043 | ||
| YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. | Q44387498 | ||
| Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1. | Q46465986 | ||
| YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9. | Q46720467 | ||
| The design and synthesis of YC-1 analogues as probes for soluble guanylate cyclase | Q46834469 | ||
| Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. | Q52526450 | ||
| Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors | Q58615288 | ||
| Identification of HSP60 as a Primary Target ofo-Carboranylphenoxyacetanilide, an HIF-1α Inhibitor | Q58615302 | ||
| P433 | issue | 11 | |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 1455 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | MedChemComm | Q3303881 |
| P1476 | title | Synthesis and biological activity of furanylindazoles as inhibitors of hypoxia inducible factor (HIF)-1 transcriptional activity | |
| P478 | volume | 3 |
| Q58615154 | Diaryl-substituted carboranes as inhibitors of hypoxia inducible factor-1 transcriptional activity |
| Q42708217 | Diaryl-substituted ortho-carboranes as a new class of hypoxia inducible factor-1α inhibitors. |
| Q47254418 | Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A "structure-activity relationship" perspective. |
| Q38866132 | The design, synthesis, and biological evaluation of novel YC-1 derivatives as potent anti-hepatic fibrosis agents |
Search more.